(TheNewswire)
Toronto, Ontario / TheNewswire / September 5,
2018 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the
“Company”, TSXV:VPT) announces that it has closed the first tranche of its
non-brokered private placement announced on August 15, 2018 (the “Private
Placement”).
The Company issued to one investor 2,380,952 units (“Units”) at $0.21 per
Unit for total gross proceeds of up to $500,000 (the “Offering”). Each Unit consists of one
common share of Ventripoint (“Common Share”) and one-half of one Common Share warrant
(“Warrant”). Each whole Warrant will entitle the holder thereof to acquire one additional
Common Share at a price of $0.34 per Common Share for a period of 2 years after the issuance of the
Warrant.
The Corporation will use the proceeds of the Private Placement for sales and marketing, development and general
working capital purposes.
After these issuances, the Company will have 57,274,524 shares outstanding. The Common Shares and the
Warrants issued pursuant to the Offering, and any Common Shares issued upon the exercise of Warrants, are subject to a hold period
of four months plus one day from the date of issuance under the rules of the TSX Venture Exchange (the “TSXV”). The Private Placement is subject to approval by the TSXV.
As announced, the total size of the Private Placement is up to $1,000,000. The Company intends to close the
second tranche of the Private Placement in the near future.
About Ventripoint Diagnostics Ltd.
Ventripoint’s technology is a leading Artificial Intelligence (AI) approach known as Knowledge-Based
Reconstruction (KBR), used to create applications to monitor heart disease, a leading cause of death worldwide. The VMS+ is the
first cost-effective and accurate AI tool for measuring whole heart function using conventional ultrasound. The Company has
developed a suite of applications for all major heart diseases and is actively commercializing the approach to improve cardiac
care.
For further information, please contact:
Dr. George Adams, CEO, Telephone: (519) 803-6937
Email: gadams@ventripoint.com
Forward Looking Statements:
This news release contains forward-looking statements and forward-looking information within the meaning of
applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing",
"may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking
information or statements. In particular, this news release contains forward-looking information relating to the Offering and the
use of the proceeds therefrom. The forward-looking statements and information are based on certain key
expectations and assumptions made by the
Corporation, including expectations and assumptions concerning the
completion of the second tranche of the Offering and the use of net proceeds of the Offering. Although the Corporation believes
that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue
reliance should not be placed on the forward looking statements and information because the Corporation can give no assurance that
they will prove to be correct.
Since forward-looking statements and information address future events and conditions, by their very
nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due
to a number of factors and risks. Such factors may include the failure to successfully market the Units and failure to satisfy
certain conditions in connection with the issuance of the Units. Other factors which could materially affect such forward-looking
information are described in the risk factors in the Corporation's most recent annual management’s discussion and analysis that is
available on the Corporation’s profile on SEDAR at www.sedar.com. Readers are cautioned that
the foregoing list of factors is not exhaustive. The forward-looking statements included in this news release are expressly
qualified by this cautionary statement. The forward-looking statements and information contained in this news release are made as
of the date hereof and the Corporation undertakes no obligation to update publicly or revise any forward-looking statements or
information, whether as a result of new information, future events or otherwise, unless so required by applicable securities
laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN
THE UNITED STATES
Copyright (c) 2018 TheNewswire - All rights reserved.